Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Soumit Roy is an analyst at Jones Trading. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/18/2025
Buy Now | Get Alert | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
03/13/2025 | CRVO | Buy Now | CervoMed | $9.48 | 58.23% | Soumit Roy32% | → $15 | Upgrade | Hold → Buy | Get Alert |
03/12/2025 | NUVB | Buy Now | Nuvation Bio | $1.91 | 423.01% | Soumit Roy32% | → $10 | Initiates | → Buy | Get Alert |
03/10/2025 | BEAM | Buy Now | Beam Therapeutics | $22.76 | 49.41% | Soumit Roy32% | → $34 | Upgrade | Hold → Buy | Get Alert |
03/06/2025 | CMRX | Buy Now | Chimerix | $8.47 | 0.94% | Soumit Roy32% | → $8.55 | Downgrade | Buy → Hold | Get Alert |
02/11/2025 | INAB | Buy Now | IN8bio | $0.23 | 424.02% | Soumit Roy32% | → $1.2 | Upgrade | Hold → Buy | Get Alert |
01/28/2025 | OKUR | Buy Now | OnKure Therapeutics | $4.61 | 594.14% | Soumit Roy32% | → $32 | Initiates | → Buy | Get Alert |
01/27/2025 | MURA | Buy Now | Mural Oncology | $4.20 | 280.95% | Soumit Roy32% | → $16 | Initiates | → Buy | Get Alert |
12/10/2024 | CRVO | Buy Now | CervoMed | $9.48 | — | Soumit Roy32% | — | Downgrade | Buy → Hold | Get Alert |
11/01/2024 | EPIX | Buy Now | ESSA Pharma | $1.61 | — | Soumit Roy32% | — | Downgrade | Buy → Hold | Get Alert |
10/31/2024 | ELTX | Buy Now | Elicio Therapeutics | $8.70 | 3.45% | Soumit Roy32% | → $9 | Initiates | → Buy | Get Alert |
10/31/2024 | ELVN | Buy Now | Enliven Therapeutics | $20.28 | 77.51% | Soumit Roy32% | → $36 | Initiates | → Buy | Get Alert |
10/31/2024 | ORIC | Buy Now | ORIC Pharmaceuticals | $7.63 | 122.8% | Soumit Roy32% | → $17 | Initiates | → Buy | Get Alert |
09/17/2024 | BEAM | Buy Now | Beam Therapeutics | $22.76 | — | Soumit Roy32% | — | Initiates | → Hold | Get Alert |
09/17/2024 | EDIT | Buy Now | Editas Medicine | $1.35 | 863.03% | Soumit Roy32% | → $13 | Initiates | → Buy | Get Alert |
09/11/2024 | ACET | Buy Now | Adicet Bio | $0.78 | 412.62% | Soumit Roy32% | $6 → $4 | Maintains | Buy | Get Alert |
08/12/2024 | INAB | Buy Now | IN8bio | $0.23 | — | Soumit Roy32% | — | Downgrade | Buy → Hold | Get Alert |
07/01/2024 | SAVA | Buy Now | Cassava Sciences | $2.81 | — | Soumit Roy32% | — | Downgrade | Buy → Hold | Get Alert |
06/14/2024 | INAB | Buy Now | IN8bio | $0.23 | 2738.43% | Soumit Roy32% | $5 → $6.5 | Maintains | Buy | Get Alert |
05/29/2024 | CRVO | Buy Now | CervoMed | $9.48 | 638.4% | Soumit Roy32% | → $70 | Initiates | → Buy | Get Alert |
05/15/2024 | BOLT | Buy Now | Bolt Biotherapeutics | $0.40 | — | Soumit Roy32% | — | Downgrade | Buy → Hold | Get Alert |
04/29/2024 | DCPH | Buy Now | Deciphera Pharmaceuticals | — | — | Soumit Roy32% | → $25.6 | Downgrade | Buy → Hold | Get Alert |
04/17/2024 | CGEM | Buy Now | Cullinan Therapeutics | $8.93 | 191.15% | Soumit Roy32% | $22 → $26 | Maintains | Buy | Get Alert |
04/16/2024 | JANX | Buy Now | Janux Therapeutics | $30.93 | 126.32% | Soumit Roy32% | → $70 | Initiates | → Buy | Get Alert |
04/11/2024 | MNPR | Buy Now | Monopar Therapeutics | $32.70 | -93.88% | Soumit Roy32% | → $10 | Upgrade | Hold → Buy | Get Alert |
03/13/2024 | INAB | Buy Now | IN8bio | $0.23 | 2083.41% | Soumit Roy32% | → $5 | Initiates | → Buy | Get Alert |
10/31/2023 | DCPH | Buy Now | Deciphera Pharmaceuticals | — | — | Soumit Roy32% | — | Upgrade | Hold → Buy | Get Alert |
10/06/2023 | CGEM | Buy Now | Cullinan Oncology | $8.93 | 146.36% | Soumit Roy32% | → $22 | Initiates | → Buy | Get Alert |
08/21/2023 | TCON | Buy Now | TRACON Pharma | $0.03 | — | Soumit Roy32% | — | Downgrade | Buy → Hold | Get Alert |
08/18/2023 | ACRV | Buy Now | Acrivon Therapeutics | $5.36 | 385.07% | Soumit Roy32% | → $26 | Initiates | → Buy | Get Alert |
05/24/2023 | ONCY | Buy Now | Oncolytics Biotech | $0.60 | 1397.01% | Soumit Roy32% | → $9 | Initiates | → Buy | Get Alert |
05/23/2023 | RAIN | Buy Now | Rain Oncology | $1.95 | — | Soumit Roy32% | — | Downgrade | Buy → Hold | Get Alert |
04/19/2023 | COEP | Buy Now | Coeptis Therapeutics | $9.70 | -58.76% | Soumit Roy32% | → $80 | Initiates | → Buy | Get Alert |
04/12/2023 | AGLE | Buy Now | Aeglea BioTherapeutics | — | — | Soumit Roy32% | — | Downgrade | Buy → Hold | Get Alert |
01/06/2023 | DCPH | Buy Now | Deciphera Pharmaceuticals | — | — | Soumit Roy32% | — | Upgrade | Sell → Hold | Get Alert |
11/16/2022 | IKT | Buy Now | Inhibikase Therapeutics | $2.11 | — | Soumit Roy32% | — | Downgrade | Buy → Hold | Get Alert |
11/08/2022 | HCWB | Buy Now | HCW Biologics | $0.32 | 2431.65% | Soumit Roy32% | → $8 | Initiates | → Buy | Get Alert |
10/31/2022 | AVEO | Buy Now | AVEO Pharmaceuticals | — | — | Soumit Roy32% | → $15 | Downgrade | Buy → Hold | Get Alert |
06/23/2022 | RAIN | Buy Now | Rain Oncology | $1.95 | 771.79% | Soumit Roy32% | → $17 | Initiates | → Buy | Get Alert |
04/01/2022 | SBTX | Buy Now | Silverback Therapeutics | — | — | Soumit Roy32% | — | Downgrade | Buy → Hold | Get Alert |
07/15/2021 | IKT | Buy Now | Inhibikase Therapeutics | $2.11 | 468.72% | Soumit Roy32% | → $72 | Initiates | → Buy | Get Alert |
05/27/2021 | SBTX | Buy Now | Silverback Therapeutics | — | — | Soumit Roy32% | → $50 | Initiates | → Buy | Get Alert |
04/29/2021 | ACET | Buy Now | Adicet Bio | $0.78 | 4129.14% | Soumit Roy32% | → $33 | Initiates | → Buy | Get Alert |
04/01/2021 | TCON | Buy Now | TRACON Pharma | $0.03 | 52695.03% | Soumit Roy32% | → $340 | Initiates | → Buy | Get Alert |
03/26/2021 | CYAD | Buy Now | Celyad Oncology | — | — | Soumit Roy32% | — | Downgrade | Buy → Hold | Get Alert |
03/17/2021 | SAVA | Buy Now | Cassava Sciences | $2.81 | 3815.01% | Soumit Roy32% | → $110 | Initiates | → Buy | Get Alert |
02/24/2021 | DTIL | Buy Now | Precision BioSciences | $5.05 | 434.65% | Soumit Roy32% | → $810 | Initiates | → Buy | Get Alert |
02/03/2020 | MNPR | Buy Now | Monopar Therapeutics | $32.70 | — | Soumit Roy32% | — | Initiates | → Buy | Get Alert |